XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2024
Stock-Based Compensation [Abstract]  
Schedule of Summary of Stock Option Activity A summary of stock option activity for the thirteen-week period ended March 31, 2024 under the Plans is as follows:
    Options Outstanding  
    Number of
Shares		     Weighted Average
Exercise Price per Share		     Weighted Average
Contractual Term (Years)		     Aggregate
Intrinsic Value
(in thousands)		  
Outstanding—December 31, 2023     11,716,646     $ 3.48       8.53     $ 2,756  
Options granted    
––
      
––
                  
Options exercised     (31,176 )     0.83                  
Options canceled     (307,198 )     2.86                  
Outstanding—March 31, 2024     11,378,272     $ 3.50       8.25     $ 215  
Vested and expected to vest—March 31, 2024     11,378,272     $ 3.50       8.25     $ 215  
Vested and exercisable—March 31, 2024     4,536,233     $ 4.38       4.78     $ 139  
Schedule of Summary of RSU Activity A summary of RSU activity for the thirteen-week period ended March 31, 2024 under the Plan is as follows:
   Number of RSUs   Weighted
Average
Grant Date
Fair Value		 
Unvested at December 31, 2023   58,097   $2.07 
Granted   
––
   $
––
 
Vested and released   
––
   $
––
 
Cancelled or forfeited   
––
   $
––
 
Unvested at March 31, 2024   58,097   $2.07 

 
Schedule of Stock Based Compensation Expense and Statements of Operations and Comprehensive Income (Loss) The following table summarizes stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) (in thousands):
   Thirteen-
Weeks
Ended		   Thirteen-
Weeks
Ended		 
   March 31,
2024		   April 2,
2023		 
Cost of revenues  $27   $11 
Sales and marketing   216    94 
General and administrative   1,098    165 

Total stock-based compensation expense from continuing operations

  $1,341   $270